Table 1 Patient characteristics and results of labwork in patients with and without cachexia
all patients N = 198 | without cachexia N = 119 [60.1%] | with cachexia N = 79 [39.9%] | p value | |
|---|---|---|---|---|
gender | male | 67 [56.3] | 49 [62] | P = 0.425 |
female | 52 [43.7] | 30 [38] | ||
ASA classification | I | 2 [1.7] | 1 [1.3] | P = 0.023 |
II | 57 [47.9] | 26 [32.9] | ||
III | 60 [50.4] | 50 [63.3] | ||
IV | 0 [0] | 2 [2.5] | ||
resection rate | 95 [79.8] | 38 [48.1] | P < 0.001 | |
metastases | 29 [24.4] | 37 [46.8] | P < 0.001 | |
tumour stage | UICC II | 83 [69.7] | 37 [46.8] | P < 0.001 |
UICC III | 7 [5.9] | 5 [6.3] | ||
UICC IV | 29 [24.4] | 37 [46.8] | ||
30-day mortality | 4 [3.4] | 4 [5.1] | P = 0.561 | |
morbidity | 50 [42.0] | 36 [46.2] | P = 0.568 | |
albumin | [g/l] | 44.2 [41.1/46.1] | 41.45 [39.5/43.8] | P < 0.001 |
CA19-9 | [U/l] | 165.0 [41.3/579.0] | 308.0 [43.7/1454.0] | P = 0.163 |
CrP | [mg/l] | 5.0 [1.0/11.3] | 9.4 [3.0/32.8] | P = 0.002 |
haemoglobin | [g/dl] | 13.3 [12.15/14.35] | 12.8 [11.8/13.7] | P = 0.023 |
protein | [g/l] | 73.9 [71.1/77.4] | 72.2 [68.55/75.75] | P = 0.037 |
resected patients N = 133 | without cachexia N = 95 [71.4%] | with cachexia N = 38 [28.6%] | P value | |
ASA classification | I | 2 [2.1] | 0 [0] | P = 0.363 |
II | 48 [50.5] | 17 [44.7] | ||
III | 2 [47.4] | 21 [55.3] | ||
30-day mortality | 2 [2.1] | 1 [2.6] | P = 0.854 | |
morbidity | 43 [45.3] | 36 [46.2] | P = 0.144 | |
albumin | [g/l] | 44.1 [40.9/45.9] | 41.6 [39.5/43.9] | P = 0.010 |
CA19-9 | [U/l] | 151.0 [34.0/416.0] | 203.6 [25.25/721.0] | P = 0.657 |
CrP | [mg/l] | 5.1 [1.0/11.8] | 6.6 [2.2/16.2] | P = 0.282 |
haemoglobin | [g/dl] | 13.1 [12.05/14.25] | 13.1 [12/13.7] | P = 0.349 |
protein | [g/l] | 73.8 [71.1/77.2] | 70.75 [68.6/75.25] | P = 0.053 |
Tumor size | T3 | 92 [96.8] | 38 [100] | P = 0.270 |
T4 | 3 [3.2] | 0 [0] | ||
grade | G1 | 4 [4.3] | 4 [11.1] | P = 0.166 |
G2 | 57 [61.3] | 23 [63.9] | ||
G3 | 32 [34.4] | 9 [25.0] |